NephroGenex, Inc. (NASDAQ:NRX) [Trend Analysis] released that it filed a voluntary petition under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware. In connection with its decision to seek Chapter 11 protection, NephroGenex has retained the investment banking firm of Cassel Salpeter & Co., LLC, to assist with the anticipated sale of its assets through a sale process under Section 363 of the Bankruptcy Code.
To that end, NephroGenex anticipates that it will seek approval by the Court of appropriate bidding and sale procedures in the early weeks of its Chapter 11 case. Chairman of the Board of NephroGenex, Richard J. Markham stated that the Board and management team have conducted a rigorous assessment of all of our strategic alternatives and believe that this process represents the best possible solution for NephroGenex, taking into account our financial situation.
NephroGenex, Inc. (NASDAQ:NRX) luring active investment momentum, shares a loss -63.04% to $0.17. The total volume of 2.13 Million shares held in the session was surprisingly higher than its average volume of 199.86 shares. EPS estimates indicating constrictive facts, the current year from sell-side analysts, Price to current year EPS stands at -6.30%.
Halyard Health, Inc. (NYSE:HYH) [Trend Analysis] deprived of allegations in a “60 Minutes” report that medical products and devices maker deliberately sold defective protective equipment to health-care workers after recent Ebola outbreak. Halyard Health, which was spun off from Kimberly-Clark Corp. in 2014, reiterated Monday that its Microcool gowns have received fewer than one complaint for every million gowns sold and that it hasn’t heard of a health-care professional being infected as a result of a flaw in its product. Halyard Health added that the “60 Minutes” report, which aired Sunday on CBS, was based in part on a test conducted by a competitor in 2012, which the company called an “outlier.” The results showed that 77% of its Microcool gowns had failed testing.
Several matter pinch shares of Halyard Health, Inc. (NYSE:HYH), as shares plunging -4.30% to $26.95 with a share volume of 2.12 Million. The stock is going forward its 52-week low with 18.41% and moving down from its 52-week high price with -45.33%. To have technical analysis views, liquidity ratio of a company was calculated 2.10 as evaluated with its debt to equity ratio of 0.55. The float short ratio was 8.67%, as compared to sentiment indicator; Short Ratio was 9.76.